(Q55012206)

15 June 2018

title

Inhibition of topoisomerase II by a novel antitumor cyclic depsipeptide, BE-22179. (English)

1 reference

15 June 2018

author name string

T Yoshinari

1

1 reference

15 June 2018

H Okada

2

1 reference

15 June 2018

A Yamada

3

1 reference

15 June 2018

D Uemura

4

1 reference

15 June 2018

H Oka

5

1 reference

15 June 2018

H Suda

6

1 reference

15 June 2018

A Okura

7

1 reference

15 June 2018

publication date

1 May 1994

1 reference

15 June 2018

number of pages

6

1 reference

Japanese Journal of Cancer Research

inferred from page(s)

published in

1 reference

15 June 2018

volume

85

1 reference

15 June 2018

issue

5

1 reference

15 June 2018

page(s)

550-555

1 reference

15 June 2018

[Inhibition of RNA syntheses under the action of antibiotic 6270 from echinomycin group in bacterial and animal cells]

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5919495

Echinomycin: the first bifunctional intercalating agent in clinical trials

16 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5919495

Phase I study of echinomycin.

16 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5919495

DNA topoisomerases in cancer therapy.

16 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5919495

Purification of topoisomerase II from amsacrine-resistant P388 leukemia cells. Evidence for two forms of the enzyme

16 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5919495

Biochemical characteristics and physiological significance of major DNA topoisomerases

16 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5919495

DNA topoisomerase poisons as antitumor drugs

16 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5919495

Comparison of in vitro anticancer-drug-screening data generated with a tetrazolium assay versus a protein assay against a diverse panel of human tumor cell lines

16 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5919495

Nonintercalative antitumor drugs interfere with the breakage-reunion reaction of mammalian DNA topoisomerase II

16 June 2018

1 reference

12 December 2020

Adriamycin-induced DNA damage mediated by mammalian DNA topoisomerase II

1 reference

12 December 2020

The molecular structure of a DNA-triostin A complex

1 reference

12 December 2020

Intercalative antitumor drugs interfere with the breakage-reunion reaction of mammalian DNA topoisomerase II

1 reference

12 December 2020

Induction of topoisomerase I-mediated DNA cleavage by a new indolocarbazole, ED-110

1 reference

12 December 2020

A new topoisomerase II inhibitor, BE-22179, produced by a streptomycete. I. Producing strain, fermentation, isolation and biological activity

1 reference

12 December 2020

10.1111/J.1349-7006.1994.TB02394.X

Identifiers

DOI

1 reference

15 June 2018

PMCID

5919495

1 reference

15 June 2018

PubMed ID

8014113

1 reference

15 June 2018